Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 156

    1.

    Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha.

    Zylberberg H, Chaix ML, Bréchot C.

    Ann Intern Med. 2000 May 16;132(10):845-6. No abstract available. PMID: 10819720 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Hepatitis C virus genotype 4: epidemiology and treatment]

    Castera L, Morice Y, Grando V, Bon C, Dény P, Roulot D.

    Gastroenterol Clin Biol. 2003 Jun;27(6-7):596-604. Review. French. No abstract available. PMID: 12910223 [PubMed - indexed for MEDLINE]Related articles

    3.

    Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype.

    McCaughan GW, Strasser SI.

    Aust N Z J Med. 2000 Dec;30(6):644-6. No abstract available. PMID: 11198570 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hepatic hepatitis C virus RNA in chronic hepatitis C.

    Craxì A, Di Marco V, Almasio PL.

    Ann Intern Med. 1996 Jan 1;124(1 Pt 1):72. No abstract available. PMID: 7503483 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha.

    Sherman M, Marinos G, Sedarati F.

    Ann Intern Med. 2001 Nov 20;135(10):927-8. No abstract available. PMID: 11712887 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interferon for hepatitis C patients with psychiatric disorders.

    Rifai MA, Bozorg B, Rosenstein DL.

    Am J Psychiatry. 2004 Dec;161(12):2331-2; author reply 2332-4. No abstract available. PMID: 15569919 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Treatment of hepatitis C virus infection]

    Zeuzem S.

    Praxis (Bern 1994). 2005 May 4;94(18):721-6. Review. German. PMID: 15938383 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hepatitis C: changing genotype distribution with important implications for patient management.

    van Soest H, Boland GJ, van Erpecum KJ.

    Neth J Med. 2006 Apr;64(4):96-9. Review.PMID: 16609154 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Hepatitis C]

    Moradpour D, Blum HE.

    Ther Umsch. 2004 Aug;61(8):493-8. Review. German. PMID: 15457965 [PubMed - indexed for MEDLINE]Related articles

    11.

    The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.

    Herion D, Hoofnagle JH.

    Hepatology. 1997 Mar;25(3):769-71. No abstract available. PMID: 9049233 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin.

    Diago M, Hassanein T, Rodés J, Ackrill AM, Sedarati F.

    Ann Intern Med. 2004 Jan 6;140(1):72-3. No abstract available. PMID: 14706990 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Treatment of patients with hepatitis C virus on the waiting list.

    Everson GT.

    Liver Transpl. 2003 Nov;9(11):S90-4.PMID: 14586902 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Association between type II cryoglobulinemia and hepatitis C virus in a case treated with interferon-alpha.

    Fukumoto S, Ishimura E, Shoji S, Izumotani T, Kitahashi S, Kuroki T, Nishizawa Y, Morii H.

    Nephron. 1996;73(1):94-6. No abstract available. PMID: 8742965 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hepatitis C virus genotype 4 and response to combination therapy with interferon-alpha2b plus ribavirin.

    Bruno S, Crosignani A, Pinzello GB.

    Ann Intern Med. 2000 Dec 5;133(11):922-3. No abstract available. PMID: 11103071 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Drug-resistant viral hepatitis.

    Wright M, Main J, Thomas HC.

    J Infect. 2000 Jul;41(1):1-4. Review. No abstract available. PMID: 10942634 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.

    Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H.

    J Med Virol. 2008 Aug;80(8):1363-9.PMID: 18551610 [PubMed - indexed for MEDLINE]Related articles

    18.

    Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment.

    Gürsoy M, Gür G, Arslan H, Ozdemir N, Boyacioglu S.

    J Viral Hepat. 2001 Jan;8(1):70-7.PMID: 11155154 [PubMed - indexed for MEDLINE]Related articles

    19.

    Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.

    Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J.

    J Med Virol. 2006 Mar;78(3):365-71.PMID: 16419107 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus.

    Neumann AU, Lam NP, Dahari H, Davidian M, Wiley TE, Mika BP, Perelson AS, Layden TJ.

    J Infect Dis. 2000 Jul;182(1):28-35. Epub 2000 Jul 6.PMID: 10882578 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data